Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, 510080, China.
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):561-569. doi: 10.1016/j.numecd.2020.10.005. Epub 2020 Oct 15.
BACKGROUND AND AIMS: Serum uric acid (UA) and high-density lipoprotein cholesterol (HDL-C) disorders are both considered as risk factors of cardiovascular mortality. The predictive value of UA to HDL-C ratio (UHR) has been validated in diabetes. However, association of UHR with cardiovascular (CV) mortality is undetermined in peritoneal dialysis (PD) patients. METHODS AND RESULTS: In this retrospective cohort study, we enrolled 1953 eligible incident patients who commenced PD treatment on our hospital from January 1, 2006 to December 31, 2015, and followed up until December 31, 2019. Of the participants, 14.9% were older than 65 years (mean age 47.3 ± 15.2 years), 24.6% were diabetics, and 59.4% were male. Patients were categorized into quartiles according to baseline UHR level. Multivariate Cox Proportional Regression analysis was applied to explore the association of UHR with mortality. Overall, 567 patients died during a median follow-up period of 61.3 months, of which 274 (48.3%) were attributed to CV death. The mean baseline UHR was 16.4 ± 6.7%. Compared to quartile 2 UHR, hazard ratios (HRs) for the highest quartile UHR were 1.35 (95% confidence interval [CI] 1.06-1.78; P = 0.017) and 1.46 (95% CI 1.00-2.12; P = 0.047) for all-cause and CV mortality, respectively. Subgroup analysis showed that association of UHR with CV mortality was remarkable among PD patients with age ≥65 years, malnutrition (albumin <35 g/L), diabetes, and CVD history. CONCLUSIONS: An elevated UHR predicted increased risk of all-cause and CV mortality in PD patients.
背景与目的:血清尿酸(UA)和高密度脂蛋白胆固醇(HDL-C)异常均被认为是心血管死亡率的危险因素。UA 与高密度脂蛋白胆固醇比值(UHR)的预测价值已在糖尿病患者中得到验证。然而,UHR 与腹膜透析(PD)患者心血管(CV)死亡率的相关性尚不确定。
方法与结果:在这项回顾性队列研究中,我们纳入了 1953 名符合条件的首发 PD 患者,这些患者于 2006 年 1 月 1 日至 2015 年 12 月 31 日在我院开始 PD 治疗,并随访至 2019 年 12 月 31 日。参与者中,14.9%的患者年龄大于 65 岁(平均年龄 47.3±15.2 岁),24.6%的患者患有糖尿病,59.4%的患者为男性。根据基线 UHR 水平将患者分为四分位组。采用多变量 Cox 比例风险回归分析探讨 UHR 与死亡率的关系。总体而言,在中位随访时间为 61.3 个月期间,共有 567 名患者死亡,其中 274 名(48.3%)死于 CV 死亡。平均基线 UHR 为 16.4±6.7%。与 UHR 四分位 2 相比,UHR 最高四分位的全因死亡和 CV 死亡的危险比(HRs)分别为 1.35(95%置信区间 [CI] 1.06-1.78;P=0.017)和 1.46(95% CI 1.00-2.12;P=0.047)。亚组分析显示,UHR 与 CV 死亡率的相关性在年龄≥65 岁、营养不良(白蛋白<35g/L)、糖尿病和 CVD 病史的 PD 患者中更为显著。
结论:升高的 UHR 预测 PD 患者全因和 CV 死亡率的风险增加。
Nutr Metab Cardiovasc Dis. 2021-2-8
Nutr Metab Cardiovasc Dis. 2021-6-30
Clin J Am Soc Nephrol. 2014-4
Nutr Metab Cardiovasc Dis. 2016-1